(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Groupon, Pacific Biosciences of California, and VerifyMe.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Groupon (GRPN) | 4.16 | 23.44% | 2023-03-31 14:50:58 |
| 2 | Pacific Biosciences of California (PACB) | 11.56 | 18.44% | 2023-03-31 14:54:45 |
| 3 | VerifyMe (VRME) | 1.85 | 16.35% | 2023-03-31 14:56:48 |
| 4 | Arcturus Therapeutics (ARCT) | 23.93 | 15.94% | 2023-03-31 14:58:34 |
| 5 | FuboTV (FUBO) | 1.22 | 15.71% | 2023-03-31 14:47:39 |
| 6 | BlackBerry (BB) | 4.61 | 15.25% | 2023-03-31 14:47:50 |
| 7 | American Public Education (APEI) | 5.44 | 11.02% | 2023-03-31 14:56:18 |
| 8 | Redfin (RDFN) | 9.05 | 10.85% | 2023-03-31 14:56:32 |
| 9 | SmileDirectClub (SDC) | 0.43 | 10.62% | 2023-03-31 14:46:22 |
| 10 | Marathon (MARA) | 8.62 | 10.09% | 2023-03-31 14:47:39 |
The three biggest losers today are Nikola, Bilibili, and Safeguard Scientifics New.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Nikola (NKLA) | 1.21 | -13.93% | 2023-03-31 14:45:26 |
| 2 | Bilibili (BILI) | 23.51 | -6.05% | 2023-03-31 14:55:17 |
| 3 | Safeguard Scientifics New (SFE) | 1.65 | -5.17% | 2023-03-31 01:41:18 |
| 4 | San Juan Basin Royalty Trust (SJT) | 10.15 | -4.61% | 2023-03-31 03:11:07 |
| 5 | Micron Technology (MU) | 60.23 | -4.53% | 2023-03-31 14:53:43 |
| 6 | Viking Therapeutics (VKTX) | 16.58 | -4.3% | 2023-03-31 14:47:35 |
| 7 | U.S. Gold Corp (USAU) | 5.55 | -4.22% | 2023-03-31 14:47:31 |
| 8 | RPC (RES) | 7.61 | -4.16% | 2023-03-30 19:46:16 |
| 9 | Generac Holdlings (GNRC) | 107.60 | -3.9% | 2023-03-31 14:53:50 |
| 10 | NeuroMetrix (NURO) | 1.42 | -3.4% | 2023-03-31 14:08:37 |
Winners today
1. Groupon (GRPN) – 23.44%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon rising 23.44% to $4.16 on Friday while NASDAQ jumped 1.74% to $12,221.91.
: groupon stock pops as company switches up its CEOGiven this, we believe that he will seamlessly transition into this new leadership role and help the company execute against and continue to refine the supply-led transformation strategy we announced during our fourth quarter earnings call. Groupon shares were ahead more than 6% in premarket trading Friday.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-10.067.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.5%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Groupon’s stock is considered to be overbought (>=80).
Sales Growth
Groupon’s sales growth is negative 27.6% for the present quarter and negative 0.5% for the next.
More news about Groupon.
2. Pacific Biosciences of California (PACB) – 18.44%
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
NASDAQ ended the session with Pacific Biosciences of California jumping 18.44% to $11.56 on Friday while NASDAQ rose 1.74% to $12,221.91.
Earnings Per Share
As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-0.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.78%.
Volatility
Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.41%, a negative 0.07%, and a positive 3.95%.
Pacific Biosciences of California’s highest amplitude of average volatility was 3.00% (last week), 3.79% (last month), and 3.95% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 7.4%, now sitting on 136.97M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 16.1% and positive 5.4% for the next.
Yearly Top and Bottom Value
Pacific Biosciences of California’s stock is valued at $11.56 at 17:32 EST, way below its 52-week high of $14.20 and way above its 52-week low of $3.85.
More news about Pacific Biosciences of California.
3. VerifyMe (VRME) – 16.35%
VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners the ability to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, authentication, serialization, and track and trace features for labels, packaging, and products. This segment also offers consumer engagement capabilities, custom printing of tamper evident labels, utilizing visible and invisible variable codes, and images printed with its proprietary inks. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Rochester, New York.
NASDAQ ended the session with VerifyMe jumping 16.35% to $1.85 on Friday while NASDAQ rose 1.74% to $12,221.91.
Earnings Per Share
As for profitability, VerifyMe has a trailing twelve months EPS of $-1.483.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.7%.
Volatility
VerifyMe’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.16%, a negative 0.32%, and a positive 4.06%.
VerifyMe’s highest amplitude of average volatility was 2.75% (last week), 3.31% (last month), and 4.06% (last quarter).
Volume
Today’s last reported volume for VerifyMe is 131093 which is 326.36% above its average volume of 30747.
Sales Growth
VerifyMe’s sales growth is 2547.1% for the current quarter and 3626.7% for the next.
Yearly Top and Bottom Value
VerifyMe’s stock is valued at $1.85 at 17:32 EST, way below its 52-week high of $3.59 and way above its 52-week low of $1.01.
More news about VerifyMe.
4. Arcturus Therapeutics (ARCT) – 15.94%
Arcturus Therapeutics Holdings Inc. operates as a late-stage clinical mRNA medicines and vaccines company. Its technologies include LUNAR lipid-mediated delivery; STARR mRNA Technology (samRNA); and mRNA drug substance. The company's pipeline of RNA therapeutic and vaccine candidates includes mRNA vaccine programs for SARS-CoV-2 (COVID-19) and Influenza, and other programs to treat ornithine transcarbamylase (OTC) deficiency, and cystic fibrosis with partnered programs, including glycogen storage disease type III and hepatitis B virus. Its RNA therapeutics platforms can be applied in multiple types of nucleic acid medicines, including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Its technologies are covered by its patent portfolio, including patents and patent applications issued in the U.S., Europe, Japan, China, and other countries. The company was founded in 2013 and is headquartered in San Diego, California.
NASDAQ ended the session with Arcturus Therapeutics jumping 15.94% to $23.93 on Friday while NASDAQ rose 1.74% to $12,221.91.
Earnings Per Share
As for profitability, Arcturus Therapeutics has a trailing twelve months EPS of $-3.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.46%.
Sales Growth
Arcturus Therapeutics’s sales growth is 1154.4% for the present quarter and 1235.8% for the next.
Moving Average
Arcturus Therapeutics’s worth is way higher than its 50-day moving average of $18.12 and way higher than its 200-day moving average of $17.24.
Volatility
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 7.79%, 1.36%, and 3.28%.
Arcturus Therapeutics’s highest amplitude of average volatility was 8.92% (last week), 4.60% (last month), and 3.28% (last quarter).
More news about Arcturus Therapeutics.
5. FuboTV (FUBO) – 15.71%
fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.
NYSE ended the session with FuboTV jumping 15.71% to $1.22 on Friday, after two successive sessions in a row of losses. NYSE jumped 1.15% to $15,374.91, after five consecutive sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, FuboTV has a trailing twelve months EPS of $-3.735.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.5%.
More news about FuboTV.
6. BlackBerry (BB) – 15.25%
BlackBerry Limited provides intelligent security software and services to enterprises and governments worldwide. The company operates through three segments: Cybersecurity, IoT, and Licensing and Other. The company offers BlackBerry Cyber Suite, which provides Cylance AI and machine learning-based cybersecurity solutions, including BlackBerry Protect, an EPP and available MTD solution; BlackBerry Optics, an EDR solution that provides visibility into and prevention of malicious activity; BlackBerry Guard, a managed detection and response solution; BlackBerry Gateway, an AI-empowered ZTNA solution; and BlackBerry Persona, a UEBA solution that provides authentication by validating user identity in real time. It also provides BlackBerry Spark Unified Endpoint Management Suite, such as BlackBerry UEM, a central software component of its secure communications platform; BlackBerry Dynamics that provides a development platform and secure container for mobile applications; BlackBerry AtHoc and BlackBerry Alert secure and networked critical event management solutions; and SecuSUITE for Government, a multi-OS voice and text messaging solution, as well as BBM Enterprise, an enterprise-grade secure instant messaging solution. In addition, the company offers BlackBerry QNX, which provides Neutrino operating system and BlackBerry QNX CAR platform, and other products; BlackBerry QNX, an embedded system solution; BlackBerry Jarvis, a cloud-based binary static application security testing platform; BlackBerry Certicom cryptography and management products, and BlackBerry Radar asset monitoring solution; and BlackBerry IVY, an intelligent vehicle data platform, as well as enterprise and cybersecurity consulting services. Further, it is involved in the patent licensing and legacy service access fees business. As of February 28, 2022, it owned approximately 38,000 worldwide patents and applications. BlackBerry Limited was incorporated in 1984 and is headquartered in Waterloo, Canada.
NYSE ended the session with BlackBerry jumping 15.25% to $4.61 on Friday while NYSE rose 1.15% to $15,374.91.
Earnings Per Share
As for profitability, BlackBerry has a trailing twelve months EPS of $-1.97.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.94%.
Yearly Top and Bottom Value
BlackBerry’s stock is valued at $4.61 at 17:32 EST, way below its 52-week high of $7.97 and way higher than its 52-week low of $3.17.
Moving Average
BlackBerry’s value is way above its 50-day moving average of $3.96 and under its 200-day moving average of $4.99.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 800% and a negative 20%, respectively.
Previous days news about BlackBerry
- Blackberry (bb) reports Q4 loss, misses revenue estimates. According to Zacks on Thursday, 30 March, "While BlackBerry has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
More news about BlackBerry.
7. American Public Education (APEI) – 11.02%
American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education. The company operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. It offers 130 degree programs and 111 certificate programs in various fields of study, including business administration, health science, technology, criminal justice, education, and liberal arts, as well as national security, military studies, intelligence, and homeland security. The company also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, an associate degree in nursing, and an associate degree in medical laboratory technology. American Public Education, Inc. was incorporated in 1991 and is headquartered in Charles Town, West Virginia.
NASDAQ ended the session with American Public Education rising 11.02% to $5.44 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $12,221.91, after two consecutive sessions in a row of gains, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, American Public Education has a trailing twelve months EPS of $1.25.
PE Ratio
American Public Education has a trailing twelve months price to earnings ratio of 4.35. Meaning, the purchaser of the share is investing $4.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.53%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 607.89M for the twelve trailing months.
Volume
Today’s last reported volume for American Public Education is 257494 which is 12% below its average volume of 292634.
More news about American Public Education.
8. Redfin (RDFN) – 10.85%
Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; originates and sells mortgages; and buys and sells homes. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Redfin jumping 10.85% to $9.05 on Friday while NASDAQ jumped 1.74% to $12,221.91.
Earnings Per Share
As for profitability, Redfin has a trailing twelve months EPS of $-0.23.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.34%.
Volatility
Redfin’s last week, last month’s, and last quarter’s current intraday variation average was 1.77%, 0.97%, and 5.67%.
Redfin’s highest amplitude of average volatility was 3.96% (last week), 5.27% (last month), and 5.67% (last quarter).
Sales Growth
Redfin’s sales growth is negative 30.3% for the current quarter and negative 49.6% for the next.
Moving Average
Redfin’s value is way higher than its 50-day moving average of $7.72 and way above its 200-day moving average of $7.13.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Redfin’s stock is considered to be oversold (<=20).
More news about Redfin.
9. SmileDirectClub (SDC) – 10.62%
SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
NASDAQ ended the session with SmileDirectClub rising 10.62% to $0.43 on Friday while NASDAQ rose 1.74% to $12,221.91.
Earnings Per Share
As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.
More news about SmileDirectClub.
10. Marathon (MARA) – 10.09%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines cryptocurrencies with a focus on the blockchain ecosystem and the generation of digital assets in United States. As of December 31, 2021, it had approximately 8,115 bitcoins, which included the 4,794 bitcoins held in the investment fund. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Marathon jumping 10.09% to $8.62 on Friday while NASDAQ rose 1.74% to $12,221.91.
Marathon (mro) to advance Guinea gas mega hub with ChevronAccording to Marathon Oil chairman, president, and CEO, Lee Tillman, the announcement builds on the company’s successful partnership with the E.G. Government for more than 20 years, further leveraging and extending the life of E.G.’s world-class gas monetization infrastructure, including the crucial E.G. LNG facility, into the next decade.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-0.13.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -41.77%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be oversold (<=20).
More news about Marathon.
Losers Today
1. Nikola (NKLA) – -13.93%
Nikola Corporation operates as a technology innovator and integrator that works to develop energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery hydrogen-electric and battery-electric semi-trucks to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola dropping 13.93% to $1.21 on Friday while NASDAQ rose 1.74% to $12,221.91.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.731.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.47%.
Yearly Top and Bottom Value
Nikola’s stock is valued at $1.21 at 17:32 EST, way under its 52-week low of $1.35.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 87% and a negative 71.4%, respectively.
Volatility
Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.16%, a negative 2.13%, and a positive 4.24%.
Nikola’s highest amplitude of average volatility was 2.51% (last week), 4.98% (last month), and 4.24% (last quarter).
Previous days news about Nikola
- Nikola (nkla) receives 100 sale orders for class 8 FCEV. According to Zacks on Thursday, 30 March, "Nikola (NKLA Quick QuoteNKLA – Free Report) is celebrating a milestone of 100 sales orders for Class 8 Nikola Tre hydrogen fuel cell electric vehicles (FCEVs), for which deliveries are expected to begin in the fourth quarter of 2023. ", "Brady has been the CFO since Nov 2017 and will step down from his current position on Apr 7, 2023, but will remain employed with Nikola until Apr 28, 2023."
More news about Nikola.
2. Bilibili (BILI) – -6.05%
Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. Its platform offers a range of content, including video services, mobile games, and value-added service, as well as ACG-related comic and audio content. The company's video services include professional user generated videos, occupationally generated videos, and live broadcasting. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
NASDAQ ended the session with Bilibili falling 6.05% to $23.51 on Friday, following the last session’s upward trend. NASDAQ jumped 1.74% to $12,221.91, after two sequential sessions in a row of gains, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Bilibili has a trailing twelve months EPS of $-1.35.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.57%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 30.6% and 46.4%, respectively.
Moving Average
Bilibili’s value is higher than its 50-day moving average of $23.16 and way higher than its 200-day moving average of $21.19.
Volume
Today’s last reported volume for Bilibili is 6732120 which is 12.17% below its average volume of 7665800.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Bilibili’s stock is considered to be oversold (<=20).
More news about Bilibili.
3. Safeguard Scientifics New (SFE) – -5.17%
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.
NYSE ended the session with Safeguard Scientifics New falling 5.17% to $1.65 on Friday, after three sequential sessions in a row of losses. NYSE jumped 1.15% to $15,374.91, after five successive sessions in a row of gains, on what was an all-around positive trend exchanging session today.
Earnings Per Share
As for profitability, Safeguard Scientifics New has a trailing twelve months EPS of $-1.813.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.1%.
Volume
Today’s last reported volume for Safeguard Scientifics New is 22175 which is 28.51% above its average volume of 17255.
More news about Safeguard Scientifics New.
4. San Juan Basin Royalty Trust (SJT) – -4.61%
San Juan Basin Royalty Trust operates as an express trust in Texas. The company has a 75% net overriding royalty interest carved out of Southland's oil and natural gas interests (the Subject Interests) in properties located in the San Juan Basin in northwestern New Mexico. The Subject Interests consist of working interests, royalty interests, overriding royalty interests, and other contractual rights in 119,000 net producing acres in San Juan, Rio Arriba, and Sandoval Counties of northwestern New Mexico, as well as 1,140.0 net wells. BBVA USA serves as the trustee of the San Juan Basin Royalty Trust. The company was founded in 1980 and is based in Houston, Texas.
NYSE ended the session with San Juan Basin Royalty Trust dropping 4.61% to $10.15 on Friday, following the last session’s downward trend. NYSE jumped 1.15% to $15,374.91, after five consecutive sessions in a row of gains, on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, San Juan Basin Royalty Trust has a trailing twelve months EPS of $1.38.
PE Ratio
San Juan Basin Royalty Trust has a trailing twelve months price to earnings ratio of 7.36. Meaning, the purchaser of the share is investing $7.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1793.42%.
More news about San Juan Basin Royalty Trust.
5. Micron Technology (MU) – -4.53%
Micron Technology, Inc. designs, develops, manufactures, and sells memory and storage products worldwide. The company operates through four segments: Compute and Networking Business Unit, Mobile Business Unit, Embedded Business Unit, and Storage Business Unit. It provides memory and storage technologies comprises DRAM products, which are dynamic random access memory semiconductor devices with low latency that provide high-speed data retrieval; NAND products that are non-volatile and re-writeable semiconductor storage devices; and NOR memory products, which are non-volatile re-writable semiconductor memory devices that provide fast read speeds under the Micron and Crucial brands, as well as through private labels. The company offers memory products for the cloud server, enterprise, client, graphics, networking, industrial, and automotive markets, as well as for smartphone and other mobile-device markets; SSDs and component-level solutions for the enterprise and cloud, client, and consumer storage markets; discrete storage products in component and wafers; and memory and storage products for the automotive, industrial, and consumer markets. It markets its products through its direct sales force, independent sales representatives, distributors, and retailers; and web-based customer direct sales channel, as well as through channel and distribution partners. Micron Technology, Inc. was founded in 1978 and is headquartered in Boise, Idaho.
NASDAQ ended the session with Micron Technology dropping 4.53% to $60.23 on Friday, following the last session’s downward trend. NASDAQ jumped 1.74% to $12,221.91, after two successive sessions in a row of gains, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Micron Technology has a trailing twelve months EPS of $2.81.
PE Ratio
Micron Technology has a trailing twelve months price to earnings ratio of 21.42. Meaning, the purchaser of the share is investing $21.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.99%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 129% and a negative 129.7%, respectively.
Yearly Top and Bottom Value
Micron Technology’s stock is valued at $60.23 at 17:32 EST, way under its 52-week high of $86.24 and way higher than its 52-week low of $48.43.
Moving Average
Micron Technology’s worth is higher than its 50-day moving average of $58.79 and above its 200-day moving average of $57.14.
Revenue Growth
Year-on-year quarterly revenue growth declined by 46.9%, now sitting on 27.16B for the twelve trailing months.
More news about Micron Technology.
6. Viking Therapeutics (VKTX) – -4.3%
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
NASDAQ ended the session with Viking Therapeutics falling 4.3% to $16.58 on Friday, after five consecutive sessions in a row of gains. NASDAQ jumped 1.74% to $12,221.91, after two successive sessions in a row of gains, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.6.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.67%.
Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $16.58 at 17:32 EST, way above its 52-week high of $11.98.
Previous days news about Viking Therapeutics
- According to FXStreet on Wednesday, 29 March, "The weekly chart below shows the Viking Therapeutics shares $VKTX traded at NASDAQ. "
More news about Viking Therapeutics.
7. U.S. Gold Corp (USAU) – -4.22%
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 650 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 87 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project that consists of 103 unpatented mining claims covering approximately 3 square miles in Eureka County, Nevada. The company is based in Elko, Nevada.
NASDAQ ended the session with U.S. Gold Corp falling 4.22% to $5.55 on Friday while NASDAQ rose 1.74% to $12,221.91.
Earnings Per Share
As for profitability, U.S. Gold Corp has a trailing twelve months EPS of $-4.37.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.57%.
Volume
Today’s last reported volume for U.S. Gold Corp is 159014 which is 265.37% above its average volume of 43521.
Yearly Top and Bottom Value
U.S. Gold Corp’s stock is valued at $5.55 at 17:32 EST, way under its 52-week high of $7.60 and way above its 52-week low of $3.50.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 1500% and positive 59% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, U.S. Gold Corp’s stock is considered to be oversold (<=20).
More news about U.S. Gold Corp.
8. RPC (RES) – -4.16%
RPC, Inc., through its subsidiaries, provides a range of oilfield services and equipment for the oil and gas companies involved in the exploration, production, and development of oil and gas properties. The company operates through Technical Services and Support Services segments. The Technical Services segment offers pressure pumping, fracturing, acidizing, cementing, downhole tools, coiled tubing, snubbing, nitrogen, well control, wireline, pump down, and fishing services that are used in the completion, production, and maintenance of oil and gas wells. The Support Services segment provides a range of rental tools for onshore and offshore oil and gas well drilling, completion, and workover activities. This segment also offers oilfield pipe inspection, and pipe management and storage services, as well as well control training and consulting services. The company operates in the United States, Africa, Canada, Argentina, China, Mexico, Eastern Europe, Latin America, the Middle East, and internationally. RPC, Inc. was founded in 1984 and is headquartered in Atlanta, Georgia.
NYSE ended the session with RPC dropping 4.16% to $7.61 on Friday, after two successive sessions in a row of losses. NYSE jumped 1.15% to $15,374.91, after five consecutive sessions in a row of gains, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, RPC has a trailing twelve months EPS of $-0.29.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.12%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 442.9% and 81.8%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 79.7%, now sitting on 1.6B for the twelve trailing months.
More news about RPC.
9. Generac Holdlings (GNRC) – -3.9%
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, and other power products for the residential, and light commercial and industrial markets worldwide. The company offers engines, alternators, batteries, electronic controls, steel enclosures, and other components. It also provides residential automatic standby generators ranging in output from 7.5kW to 150kW; air-cooled engine residential standby generators ranging from 7.5kW to 26kW; liquid-cooled engine generators with outputs ranging from 22kW to 150kW; and Mobile Link, a remote monitoring system for home standby generators. In addition, the company offers various portable generators ranging in size from 800W to 17.5kW; outdoor power equipment, such as trimmers, field and brush mowers, log splitters, stump grinders, chipper shredders, lawn and leaf vacuums, pressure washers, and water pumps; and clean energy solution under the PWRcell and PWRview brands. Further, it provides light towers, mobile generators, and mobile energy storage systems; commercial mobile pumps and dust-suppression equipment; various gaseous-engine control systems and accessories; light-commercial standby generators ranging from 22kW to 150kW and related transfer switches providing three-phase power for small and mid-sized businesses; and industrial generators ranging in output from 10kW to 3,250kW used as emergency backup for healthcare, telecom, datacom, commercial office, retail, municipal, and manufacturing markets. Additionally, the company sells aftermarket service parts and product accessories to dealers. It distributes its products through independent residential dealers, industrial distributors and dealers, national and regional retailers, e-commerce partners, electrical, HVAC and solar wholesalers, catalogs, equipment rental companies and distributors, and solar installers; and directly to end users. The company was founded in 1959 and is headquartered in Waukesha, Wisconsin.
NYSE ended the session with Generac Holdlings falling 3.9% to $107.60 on Friday while NYSE jumped 1.15% to $15,374.91.
Earnings Per Share
As for profitability, Generac Holdlings has a trailing twelve months EPS of $7.12.
PE Ratio
Generac Holdlings has a trailing twelve months price to earnings ratio of 15.1. Meaning, the purchaser of the share is investing $15.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.72%.
Moving Average
Generac Holdlings’s value is under its 50-day moving average of $117.91 and way below its 200-day moving average of $160.86.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 29.9% and a negative 32.1%, respectively.
Sales Growth
Generac Holdlings’s sales growth is negative 0.2% for the ongoing quarter and negative 16.6% for the next.
More news about Generac Holdlings.
10. NeuroMetrix (NURO) – -3.4%
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix sliding 3.4% to $1.42 on Friday while NASDAQ jumped 1.74% to $12,221.91.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.42.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.47%.
Volatility
NeuroMetrix’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.14%, a negative 2.13%, and a positive 2.97%.
NeuroMetrix’s highest amplitude of average volatility was 1.54% (last week), 3.33% (last month), and 2.97% (last quarter).
Volume
Today’s last reported volume for NeuroMetrix is 15827 which is 67.42% below its average volume of 48588.
Yearly Top and Bottom Value
NeuroMetrix’s stock is valued at $1.42 at 17:32 EST, way under its 52-week high of $5.89 and higher than its 52-week low of $1.33.
More news about NeuroMetrix.
Stay up to date with our winners and losers daily report
